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HIGHLIGHTS 
Benzo[a]pyrene, a well-known environmental carcinogen, alters H+ dynamics.  
NHE1 activation by B[a]P plays a key role in H+ dynamics alterations. 
B[a]P-altered pH controls cell death/survival balance via mitochondria and lysosome. 
B[a]P impact on H+ dynamics fits with the malignant tumor-related H+ gradient reversal. 
Altered H+ dynamics might be universal mechanisms in environmental carcinogenesis. 
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ABSTRACT  
Despite the improvement of diagnostic methods and anticancer therapeutics, the human 
population is still facing an increasing incidence of several types of cancers. According to the 
World Health Organization, this growing trend would be partly linked to our environment, with 
around 20% of cancers stemming from exposure to environmental contaminants, notably 
chemicals like polycyclic aromatic hydrocarbons (PAHs). PAHs are widespread pollutants in our 
environment resulting from incomplete combustion or pyrolysis of organic material, and thus 
produced by both natural and anthropic sources; notably benzo[a]pyrene (B[a]P), i.e. the 
prototypical molecule of this family, that can be detected in cigarette smoke, diesel exhaust 
particles, occupational-related fumes, and grilled food. This molecule is a well-recognized 
carcinogen belonging to group 1 carcinogens. Indeed, it can target the different steps of the 
carcinogenic process and all cancer hallmarks. Interestingly, H+ dynamics have been described as 
key parameters for the occurrence of several, if not all, of these hallmarks. However, 
information regarding the role of such parameters during environmental carcinogenesis is still 
very scarce. The present review will thus mainly give an overview of the impact of B[a]P on H+ 
dynamics in liver cells, and will show how such alterations might impact different aspects related 
to the finely-tuned balance between cell death and survival processes, thereby likely favoring 
environmental carcinogenesis. In total, the main objective of this review is to encourage further 
research in this poorly explored field of environmental molecular toxicology. 
 
Key words: benzo[a]pyrene; extracellular acidosis; intracellular pH; mitochondria; NHE1; 
Warburg effect.  
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1-INTRODUCTION 
 
Despite the improvement of diagnostic methods and anticancer therapeutics, the human 
population is still facing an increasing incidence of several types of cancers. According to the 
World Health Organization, this growing trend would be partly linked to our environment, with 
around 20% of all cancers stemming from exposure to environmental contaminants, notably 
chemicals like pesticides, dioxins, polycyclic aromatic hydrocarbons (PAHs) or metals (e.g. 
arsenic). PAHs are widespread pollutants in our environment resulting from incomplete 
combustion or pyrolysis of organic material, and thus produced by both natural and anthropic 
sources; notably benzo[a]pyrene (B[a]P), i.e. the prototypical molecule of this family, that can be 
detected in cigarette smoke, diesel exhaust particles, occupational-related fumes, and grilled 
food. This molecule is highly lipophilic and firstly metabolized by the family 1 of cytochromes 
P450 (CYP1) that are enzymes of the phase I of xenobiotic metabolism. For several xenobiotics, 
this phase I, along with three other phases (Figure 1), usually carries out the biotransformation 
of deleterious exogenous molecules to ease their elimination by the organism [1]. However, in 
some cases, like for B[a]P, the produced metabolites are highly reactive, then forming DNA 
adducts with a high mutagenic potential. This type of action mechanism (i.e. genotoxicity), along 
with data from in vivo and epidemiological studies, have led the International Agency for 
Research on Cancer (IARC) to classify B[a]P as group 1 carcinogen for human beings (i.e. there is 
enough evidence to conclude that it can cause cancer in humans) [2]. Actually, numerous studies 
have shown that B[a]P is a complete carcinogen since it can target all steps of carcinogenesis, 
that is, initiation, promotion and progression, ultimately leading to cancer and metastasis. Based 
on literature, it even appears that this PAH can target all the cancer hallmarks defined by 
Hanahan and Weinberg in 2011 [3], and recently reviewed by our group with respect to B[a]P 
[4]. Interestingly, H+ dynamics have been described as key parameters for the occurrence of 
several, if not all, of these hallmarks [5]. However, data regarding the role of H+ dynamics during 
environmental carcinogenesis are still very scarce, and would deserve further research in the 
future. The present review has thus been undertaken in order to encourage such a research, and 
will mainly be dedicated to the impact of B[a]P on H+ homeostasis in liver cells. However, when 
necessary, data obtained with other environmental carcinogens, especially arsenic, will also be 
presented. 
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2-WHAT ARE THE ALTERATIONS IN H
+
 HOMEOSTASIS POSSIBLY INDUCED BY ENVIRONMENTAL 
CONTAMINANTS? 
 
It has long been known that pHi homeostasis is a key determinant for the maintenance of 
cellular functions; hence, pHi has to be tightly controlled. Such a homeostasis relies on both 
“short-term” (intracellular buffering power) as well as “long-term” regulation systems 
(transporters of protons or acid equivalents) [6]. Among these latter systems, one can cite the 
ubiquitous Na+/H+ exchanger isoform 1 (NHE1) whose abnormal activation has notably been 
described as playing a key role in both tumorigenesis and cell death processes [7-11]. This 
antiporter, located at the plasma membrane, extrudes 1 H+ ion against 1 Na+ ion when activated 
either upon intracellular acidification or upon mitogenic stimulation [12]. This transporter is also 
known to be sensitive to osmotic changes [13], or modifications in membrane lipid composition 
[14], and has thus been claimed as a mechano-sensitive transporter [12,13]. 
 
2-1-Effects on intracellular pH (pHi) via NHE1 activation by B[a]P 
Using microspectrofluorimetry and the pH-sensitive fluorescent probe carboxy-SNARF-1, 
we previously found biphasic changes in steady-state pHi upon exposure of rat hepatic epithelial 
F258 cells to B[a]P, even at a dose as low as 50 nM. Indeed, a transient intracellular alkalinization 
was first detected, followed by an intracellular acidification [15]. The use of cariporide, a specific 
chemical inhibitor of NHE1, allowed us to demonstrate that the alkalinization was due to an 
early activation of this pHi regulator by B[a]P, and that NHE1 activation was essential for the 
secondary acidification to occur [53], through targeting mitochondrial function [16,17]. A B[a]P-
induced intracellular alkalinization was also observed in mouse hepatoma cell line Hepa1c1c7 
[18]. The next question to be addressed was about the mechanisms underlying NHE1 activation 
in B[a]P-treated cells. B[a]P, as a lipophilic molecule, has been previously shown to directly 
increase membrane fluidity since it can very rapidly partition within plasma membrane as soon 
as cells are exposed to the compound [19]. However, even though such a phenomenon might 
have occurred under our experimental conditions, it was unlikely to be responsible for the NHE1 
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activation detected following 48h of exposure to 50 nM of B[a]P; indeed we showed that B[a]P 
had to be metabolized by CYP1 prior to alter pHi [15]. Furthermore our work indicated that the 
increase in membrane fluidity detected upon B[a]P (at 48h with 50 nM) was actually due to 
NHE1 activation [20]. NHE1 is known to be preferentially located in lipid rafts, that is, membrane 
nanodomains enriched in cholesterol and sphingolipids [14]. In B[a]P-treated hepatic cells, NHE1 
was found to be relocated outside lipid rafts, and this was necessary for NHE1 to be activated, 
likely through allowing the binding of calmodulin to the C-terminal domain of the transporter 
[21]; indeed, this binding is known to prevent the action of an autoinhibitory domain in NHE1, 
thus responsible for activation of the transporter [22,23]. The relocation outside lipid 
nanodomains was in fact due to a membrane remodeling related to a decreased level of 
cholesterol; both activation of AhR (aryl hydrocarbon receptor) and production of reactive 
oxygen species (ROS) resulting from CYP metabolism [15], were involved in this decrease 
through down-regulation of the expression of 3-hydroxy-3-methyl-glutaryl-coenzyme A 
reductase (HMG-CoA reductase), a limiting enzyme in cholesterol synthesis [24]. Other 
mechanisms to explain NHE1 activation upon chemical carcinogen exposure could also be 
involved, as the case for arsenic trioxide. Indeed, this environmental contaminant, like B[a]P, 
was shown to activate NHE1 in the Madin-Darby canine kidney (MDCK) cells; in that case, the 
authors evidenced diverse protein kinases (p42/44 Mitogen Activated Protein Kinases and 
Protein Kinases Cα, βI and/or μ), as being involved in the exchanger activation [25]. 
 
2-2-Effects on extracellular pH (pHe)  
Using the Seahorse technology that measures both oxygen consumption and 
extracellular pH (pHe), an extracellular acidification was also detected upon B[a]P exposure, and 
was found to be concomitant with intracellular alkalinization [26]. Although not tested yet, this 
decrease in pHe might have been due either to NHE1 activation or activation of lactate-H
+ co-
transport (MCT for monocarboxylate transporter). Indeed, previous studies have reported that 
both NHE1 and MCT activation, via the transport of H+ outside cells, can acidify the extracellular 
microenvironment [27-29]. Regarding the MCT transporter, we previously detected an increase 
in extracellular lactate concentration from B[a]P-treated hepatic cells [26], which might indicate 
that this transporter could play a role under our experimental conditions. However, although a 
role for MCT in the decrease of pHe has been reported in the short term [30], it might not be the 
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case in the long term.  Indeed, it has been reported that extracellular acidification in tumor cells 
would be able to inhibit the activity of MCTs; extrusion of lactate could then occur through 
connexin 43 channels (Cx43; [31]). It is worth noting that we have previously shown that B[a]P 
can increase gap junction intercellular communication through an impact on the membrane 
location of Cx43 [32]. A role for NHE1, MCT and Cx43 would thus deserve further investigation 
regarding the development of extracellular acidification and the increase in lactate efflux upon 
B[a]P exposure. 
 
2-3-Effects on the pH of organelles 
Not only pHi and pHe were altered by B[a]P, but so was the pH of organelles. Indeed, 
based upon data obtained through transfecting a plasmid allowing the mitochondrial expression 
of a pH-sensitive fluorescent probe, we detected a marked acidification of the mitochondrial 
matrix with a decrease as large as 1.5 pH unit from a physiological mitochondrial pH (pHm) ∼ 8.0 
[26].  Whereas the origin of this acidification remains as yet unknown, one possibility might be 
via activation of the mitochondrial NHE1 (mNHE1). Indeed, mNHE1 activation has been shown to 
lead to H+ influx into mitochondrial matrix, notably in cardiomyocytes, which would favor cell 
survival [33]. Interestingly, this exchanger has been described to be inhibited by cariporide [34]. 
Another possibility might be via an increase in the H+ leak related to the mitochondrial 
uncoupling proteins (UCPs), known to be located in the inner membrane. Among these proteins, 
UCP2 is known as being the most ubiquitous UCP, and appears to be overexpressed in diverse 
cancers, liver among them [35,36]. This protein can play a role in the control of ROS by lowering 
the proton-motive force necessary for ATP production by the electron transport chain (ETC; 
[37]). Interestingly, UCP2 has been shown to be a target of B[a]P; indeed, in neoplastic 
fibroblasts, this carcinogen appeared to up-regulate the expression of UCP-2 by about 70% [38]. 
It is noteworthy that UCP2, by inhibiting oxidative phosphorylation, would also favor glycolysis 
[39], such a metabolic shift (the so-called Warburg effect) being observed upon B[a]P exposure 
in F258 cells [26]. 
The pH of lysosomes can also be altered by chemical carcinogens. Indeed, we have 
shown that in F258 cells, B[a]P could induce an increase in lysosomal pH (pHL) [40]. Such an 
alkalinization might result from alterations of the physicochemical properties of lysosome 
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membranes. Indeed, under our experimental conditions, a permeabilization of this membrane 
was observed, likely resulting from mitochondria-dependent oxidative stress [40]. As a 
consequence, H+ ions would leak out of lysosomes. Interestingly, it has recently been reported 
that increasing lysosomal pH would be able to lead to cytosolic acidification [41]; such a 
communication between lysosomes and cytosol would involve changes in the interaction 
between STAT3 (signal transducer and activator of transcription-3) and the vacuolar H+-ATPase 
(v-ATPase). In this context, it would be interesting to test whether B[a]P could affect STAT3 
expression and localization in our cell model. 
 
In total, it appears that B[a]P can affect pH in different cell compartments (Figure 2). As a 
consequence, this leads to changes in various pH gradients, notably across plasma membrane, 
mitochondrial inner membrane and lysosomal membrane. Such changes could have important 
consequences in terms of cell death and survival, as described in the following section. 
 
3-WHAT MIGHT BE THE CELLULAR CONSEQUENCES OF CARCINOGENS-INDUCED ALTERATIONS IN 
PH HOMEOSTASIS? 
  
Based upon the important role of pH in the control of various cell processes, notably by 
acting on enzyme activity and protein-protein interactions, one can easily figure out that any 
disturbance in pH homeostasis will lead to alterations in cell functions. Chemical carcinogenesis 
is assumed to result from modifications of the balance between cell death and survival 
processes, in favor of cells bearing mutations, that are resistant to cell death processes and 
prone to proliferate. It is worth emphasizing here that a low level of cell death, such as the one 
induced by a chronic exposure to a low concentration of chemical carcinogens, has been 
reported as favoring the compensatory proliferation of neoplastic cells [42].  
B[a]P possesses the capacity to elicit cell signaling related on one hand to apoptosis, i.e. a 
specific type of cell death [43], and on the other hand to cell survival [44]. Thus, in F258 cells, we 
have shown that 50 nM B[a]P could trigger apoptosis, with the involvement of multiple 
pathways depending or not on the activation of caspases [15,16]. Using cariporide to inhibit 
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NHE1 activity or silencing RNA to significantly reduce NHE1 mRNA expression, we demonstrated 
that NHE1 activation, as evidenced by the intracellular alkalinization, played a key role in the 
apoptosis induced by B[a]P in F258 cells; this was actually in contrast to the largely described 
role for NHE1 activation in survival processes [5,9,10], and might be explained by the various 
functions of the transporter (pH regulator, scaffold protein for signalplex, anchor protein for 
cytoskeleton) [8], as proposed in section 3-2-1. This non-genotoxic pathway is activated in 
parallel to the classical p53 pathway (i.e. the genotoxic pathway) induced by B[a]P-related DNA 
damage [15,17]. As described below, both pathways can work together to regulate cell 
death/survival balance.   
In the following sub-sections, we will see how H+ dynamics and NHE1 can regulate both 
facets of the cell death/survival balance, through considering different cell compartments as well 
as microenvironment (Table 1); this could pave the way for a better understanding of 
environmental carcinogenesis, especially when exposures occur at low doses. 
 
3-1-pH homeostasis and modulation of biophysical characteristics of membranes 
Plasma membrane constitutes the first cellular barrier that chemical agents encounter. 
Our group previously demonstrated that B[a]P can affect membrane fluidity in diverse hepatic 
cell models [20,45]. Using cariporide, we showed that this membrane fluidization was dependent 
on NHE1 activation [20]. The underlying mechanisms still remain unknown. NHE1 is directly 
linked, through its C-terminal domain, to the actin cytoskeleton via the ERM proteins 
(ezrin/radixin/moiesin) [46,47]. Due to this property, one might first propose that NHE1 
activation might increase membrane fluidity through remodeling of actin cytoskeleton; indeed, it 
has previously been shown that cytochalasin B, a molecule known to target actin cytoskeleton, 
can increase membrane fluidity of polymorphonuclear leukocytes [48]. Another possibility might 
be through an impact of the alkaline intracellular pH. Indeed, data obtained by Astarie and 
coworkers [49] indicated that cytosolic pH could vary inversely with the steady-state anisotropy 
of the fluoroprobe trimethylamino-diphenylhexatriene (TMA-DPH; to measure membrane 
fluidity near the polar heads of lipids); in other words, an alkalinization would be related to a 
decrease in anisotropy of the probe, and hence to an increase in fluidity. Such an effect might be 
due to an effect of low proton concentration towards lipid packing [50]. Finally, we might also 
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hypothesize that changes in pH on both sides of the plasma membrane might regulate the 
activity of enzymes involved in lipid synthesis, thereby altering the lipid composition of the 
membrane and hence fluidity. For example, sphingomyelinases, whose activities depend on pH 
values, might be activated or inhibited, with consequences in terms of ceramide composition of 
plasma membrane [51]. Of note, inhibition of acid sphingomyelinase was found to prevent 
cisplatin-induced membrane fluidization that resulted from an intracellular acidification [52]. In 
our experimental context, one could thus envision an activation of sphingomyelinases by the 
B[a]P-induced alterations in H+ dynamics. Besides changing membrane fluidity, NHE1 activation 
might also have an impact on the cell surface glycoconjugate composition of cell membrane, 
with consequences in terms of membrane microstructure. Indeed, due to activation of this 
transporter, a local decrease of pHe could occur, thus activating plasma membrane-associated 
glycohydrolases [53], with consequent alterations in the ceramide content of plasma membrane 
[54,55]. In this context, it would be worth analyzing the ceramide content of plasma membrane 
upon B[a]P exposure, and, if any change, its dependence on NHE1. 
Regarding the role of the B[a]P-induced membrane fluidization, we have previously 
shown that prevention of fluidization by membrane stabilizers (eg. cholesterol or ganglioside 
GM1) significantly inhibited apoptosis [20,56]. Furthermore, we found that the increase in 
fluidity had consequences on iron homeostasis. Indeed, the increase in iron uptake detected 
upon B[a]P exposure was markedly inhibited when co-treating cells with cholesterol or 
exogenous GM1 ganglioside [20,56]. Interestingly, this metal is known to traffic through the 
endolysosomal pathway [57], and protons have been reported to favor endocytosis, notably by 
affecting membrane fluidity [58]. It is worth noting that upon B[a]P exposure, alterations of iron 
homeostasis would play a role not only in the development of oxidative stress, through the 
Fenton reaction, but also in the activation of the protease activity of lactoferrin, which would 
then allow caspase activation in F258 cells [40].  
 
3-2-H
+
 dynamics and the control of mitochondrial functions 
3-2-1-NHE1 and hexokinase II 
As NHE1 activation was found to be involved in the B[a]P-induced apoptosis, we then 
looked for the underlying intracellular mechanisms. Thus, under our experimental conditions, we 
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found that both NHE1 and p53 worked together to trigger a signaling cascade involving both the 
protein kinase GSK3α and the oncogene c-Myc, which led to the translocation of hexokinase II 
(HKII) from mitochondria to cytosol [17,59]. HKII is a key glycolytic enzyme bound to the voltage-
dependent anion channel (VDAC) located at the outer mitochondrial membrane [60]. This 
protein has dual metabolic and apoptotic functions, and its mitochondrial location is 
determinant for the regulation of these functions [60,61]. Indeed, it favors an energy shuttle 
between glycolytic ADP and mitochondrial ATP. When HKII interaction with mitochondria is 
disrupted, electron transport along the ETC is altered and the consecutive electron leakage, 
combined to oxygen, promotes the production of superoxide anion O2
.- [61]. With respect to 
B[a]P exposure, we have thus evidenced that enforced HKII mitochondrial expression prevented 
ROS production as well as apoptosis [17]. The next question still to be addressed is how the 
couple GSK3α/c-Myc would allow the translocation of HKII from mitochondria to cytosol under 
B[a]P exposure. Our previous data showed a decrease in c-Myc expression that was involved in 
HKII translocation induced by B[a]P; furthermore, we found that using a c-Myc-plasmid construct 
in order to counteract the c-Myc expression decrease, significantly inhibited the B[a]P-induced 
apoptosis while preventing the reduction of mitochondrial HKII protein level [59]. The 
implication of c-Myc might have been through its role as a regulator of glucose metabolism, 
since a reduction of this metabolism has been reported to trigger HKII translocation [62]. 
However, under our experimental conditions, an increase in glycolysis was rather seen [26], 
suggesting that other mechanisms might be involved. It has previously been shown that the 
cholesterol content of mitochondria can regulate the binding of HKII to VDAC, with a loss of this 
binding as cholesterol content decreases [63]. Besides, c-Myc has been reported to be involved 
in the regulation of the HMG-CoA reductase expression [64]. As we have shown that B[a]P 
decreases the expression of this reductase in F258 cells thus leading to a change in cholesterol 
homeostasis, one might then suppose that the role of the decreased expression of c-Myc in the 
B[a]P-induced HKII translocation might go through a decrease in the mitochondrial cholesterol 
content. Finally, note that silencing VDAC1, whose mRNA expression is also down-regulated 
during lung carcinogenesis in mice treated with B[a]P [65], has been associated with a decrease 
in c-Myc expression [66]. As a result of the decrease of VDAC expression, one might then expect 
less HKII bound to mitochondria.  
Regarding the role of NHE1 and p53 as regulators of HKII localization and mRNA 
expression [17,59], the molecular mechanisms involved still remain to be deciphered, especially 
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as these two proteins were independently activated [17]. It was previously shown by Quach et 
al. [67] that, in isolated mitochondria, acidic pH increased the release of free HKII from the 
mitochondrial pellet into the supernatant whereas alkaline pH had the opposite effect. These 
authors then concluded that a mild alkalinization was sufficient to enhance HK activity by 
favoring its mitochondrial translocation and VDAC binding, thereby enhancing glycolysis. Taking 
into account those data, it is then difficult for us to explain the link between NHE1 and HKII via 
the mere increase in pHi. As NHE1 is also known as capable of forming protein complex for 
intracellular signaling [47,68,69], one might then suggest the existence of such a complex that 
would comprise NHE1, GSK3α and p53, all necessary for c-Myc down-regulation [59]. In this 
context, it would be interesting to analyze the NHE1 interactome under B[a]P exposure. 
We have previously shown that inhibiting NHE1 resulted in the prevention of the biphasic 
change in pHi, that is, both alkalinization and secondary acidification [15]. As our data suggested 
a possible involvement of a reversal of the F0F1-ATPase activity (i.e. the ATP synthase or 
complex V located in mitochondria) in the occurrence of cytosolic acidification upon B[a]P 
exposure [16], the role of HKII translocation in the reversal of the ATP synthase and acidification 
would also be worth studying. Regarding the impact of this secondary acidification induced by 
B[a]P, it was likely involved in the activation of effector caspases and proteases (cathepsins, 
lactoferrin) as well as in the activation of the endonuclease LEI/L-DNase II, all playing a role in 
apoptosis [7,16,40]. 
 
3-2-2-H
+ 
dynamics and energy metabolism 
Work by Reshkin and coworkers has previously demonstrated a determinant role for the 
NHE1-dependent intracellular alkalinization in malignant transformation, notably by favoring 
glycolysis [70]. Alterations in cancer cell metabolism are well recognized as being one of the 
cancer hallmarks [3], and have been recently reviewed in several papers [71-74]. In this context, 
cancers are considered as metabolic diseases [75]. Up to now, the metabolic change associated 
with cancers that has received the most attention, is the so-called Warburg effect [76]. This 
effect corresponds to a shift of cell metabolism from oxidative phosphorylation (OXPHOS; relying 
upon mitochondria ETC) to aerobic glycolysis. However, it is clear now that the metabolic 
reprogramming is more complex than the mere glycolytic shift [73,74,77,78].  Regarding 
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environmental carcinogens, our previous data indicated that B[a]P, even at the lowest dose of 50 
nM, was capable of inducing a pro-survival Warburg effect in several hepatic cell lines; this was 
detected by an increase in lactate efflux and a decrease in oxygen consumption, the latter 
reflecting an inhibition of OXPHOS [26]. Interestingly, the alterations of H+ dynamics reported 
above appeared to be involved in the B[a]P-induced glycolytic shift. Indeed, in treated F258 cells, 
an inhibition of the complex II succinate quinone reductase activity (SQR) was observed without 
any change in succinate dehydrogenase activity (SDH); these effects would lead to a 
disconnection between the tricarboxylic cycle (also known as Krebs cycle) and OXPHOS [26]. 
Such changes in complex II activities were previously related to a decrease in pHm, leading to a 
dissociation of this complex [79]. As B[a]P exposure also induced an acidification of 
mitochondrial matrix (from pHm 8.0 to 6.5 [26]), one might then propose a similar mechanism 
under our experimental conditions. Another identified target of the acidification of pHm would 
be the inhibitory factor 1 (IF1). IF1 is the physiological inhibitor of the F0F1-ATPase; it binds this 
ATPase when a reverse mode of it is induced upon stress, thereby limiting ATP hydrolysis (see 
[80] for review). Activation of IF1 has been related to the acidification of pHm, which favors the 
dimeric state of the protein, hence allowing the interaction with the β subunit of the pump [81]. 
We found that B[a]P induced an increase in IF1 content of mitochondria; its silencing not only 
prevented lactate production, that is, glycolysis, but also increased cell death [82]. Taken all 
these results into consideration, we can therefore suppose that the change in pHm we detected 
might also be involved in the activation of IF1 by B[a]P. Besides a role of pHm alterations, the 
NHE1 activation induced by B[a]P also appeared to be involved in the related metabolic 
reprogramming. Indeed, inhibiting NHE1 by cariporide fully prevented the increase in lactate, 
that is, glycolysis, observed upon B[a]P exposure [26]. Whereas not studied yet under our 
experimental conditions, one might suppose a direct involvement of the NHE1-dependent 
intracellular alkalinization to favor glycolysis. Indeed, it is well known that the activity of the 
enzymes involved in the glycolytic pathway, eg. phosphofructokinase and lactate 
dehydrogenase, is sensitive to pH, as reviewed by Reshkin et al. [83]; notably this activity 
increases while pHi increases. Besides, the pH gradient between mitochondrial matrix and 
cytosol would be a key parameter for determining the activity of the transporters involved in 
OXPHOS; in this context, a reversal of this gradient, as observed with B[a]P (Figure 2), would 
negatively impact this metabolic pathway [83]. In total, it seems that this is the function of NHE1 
as a transporter of H+ that would be determinant for the metabolic reprogramming induced by 
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B[a]P, in parallel to changes in pHm. However, the impact of B[a]P on cell metabolism might also 
involve regulation of gene expression, as observed upon co-exposing lung epithelial transformed 
cells to both B[a]P and arsenic [84]. Of note, AhR activation, as triggered upon B[a]P exposure, 
appears to regulate the expression of several enzymes involved in energy metabolism; this 
cytosolic receptor is also known to interact with the F0F1ATPase (see [85] for review). In this 
context, how H+ dynamics and AhR could act together to induce metabolic reprogramming upon 
B[a]P exposure remains an open question, as previously emphasized [4].  
 
3-3-B[a]P-induced alterations in autophagy: a role for H
+
 dynamics? 
3-3-1-Autophagy: a key cellular process to cope with stressful conditions 
Macroautophagy, generally referred to as autophagy, is a physiological process, whose 
main function is to preserve cellular homeostasis by protecting cells exposed to stressful 
conditions [86,87]. Indeed, this key cellular process will more specifically act by allowing self-
digestion of toxic aggregates, damaged structures and organelles, thereby avoiding their toxic 
accumulation and ultimately allowing their recycling [88,89]. 
Hence, it is not surprising that any disruption in the fine tuning of this essential quality 
control process will favor pathogenesis, notably by promoting the accumulation of misfolded 
signaling proteins and dysfunctional mitochondria [90]. Autophagic dysfunction has thus been 
related to a wide spectrum of pathophysiological situations, including cancers [91], 
neurodegenerative [92] and cardiovascular diseases [93]. Considering carcinogenesis, autophagy 
physiologically acts as a tumor suppressor pathway during the tumor initiation step. However, 
autophagy has also been shown to sustain cancer progression, metastasis, and resistance to 
therapies [94,95]. As the present review mainly focuses on H+ dynamics and environmental 
carcinogenesis, we will not discuss here the complex and ambivalent contribution of autophagy 
to cancer progression. 
As recently reviewed, a growing number of environmental pollutants are now known to 
interfere with autophagy [96]. Non-exhaustively, cadmium [97], arsenic [98], paraquat [99], 
bisphenol A [100], patulin [101] and TCDD [102,103], have been shown to differentially affect 
autophagy. Of particular interest here, two previous studies have also reported that B[a]P can 
modulate both autophagy [104] and mitophagy [105]. 
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3-3-2-What impact for B[a]P on autophagy in F258 cells? 
Regarding B[a]P and F258 cells, we have shown that exposure of these cells to this PAH 
induced the conversion of LC3-I into LC3-II involved in the formation and closure of 
autophagosomes (Figure 3A), after 48 and 36h of exposure with 50 nM and 1 µM of B[a]P, 
respectively. We also detected a dose- and time-dependent accumulation of the cargo protein 
p62, whose function is to convey the ubiquitinated proteins in the autophagic vacuoles. For each 
experiment, chloroquine (CHL), a lysosomotropic compound known to elevate/neutralize the 
lysosomal/vacuolar pH [106], and to decrease autophago-lysosome fusion [107], was used as a 
positive control of autophagy inhibition. 
The accumulation of autophagic vacuoles was then monitored by fluorescence 
microscopy, using the Cyto-ID autophagy detection kit (Enzo Life Sciences). As shown in Figure 
3B (Green staining), B[a]P (50 nM, 24h) favored such an accumulation. Aggresomes are 
inclusion bodies that are formed when the ubiquitin–proteasome machinery is overwhelmed, 
and whose primary function is to confer a cytoprotective balance by sequestering the toxic 
aggregated proteins, therefore facilitating their degradation by autophagy. We used the 
PROTEOSTAT Aggresome detection kit (Enzo Life Sciences), based on the detection of 
ubiquitinated proteins, in order to follow by fluorescence microscopy, the distribution of these 
structures inside F258 cells exposed to B[a]P (50 nM, 24h). As illustrated in Figure 3B (Red 
staining), B[a]P-treated cells showed an increase in fluorescence signal, further indicating that 
B[a]P was responsible for a slowing-down of the aggresome recycling. Taken together, our data 
suggested that B[a]P exposure of F258 cells might also be responsible for an inhibition of 
autophagy, leading to an increased accumulation rate of damaged structures (e.g. proteins and 
organelles). 
 
3-3-3-What role for H
+
 dynamics in the B[a]P-elicited autophagic dysfunction? 
Although very scarce, the data published so far have indicated that both NHE exchangers 
and pHi might be involved in the regulation of autophagy and mitophagy [108,109]. In particular, 
it has been described that a monensin-mediated alkalinization of pHi would be able to inhibit 
mitophagy in SH-SY5Y neuroblastoma cells [109]. As in F258 cells, B[a]P induced an early NHE1-
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dependent alkalinization [15], the contribution of NHE1 in B[a]P-elicited autophagic dysfunction 
was then tested. Using cariporide, we found that inhibiting NHE1 had no effect on the B[a]P-
induced dose-dependent accumulation of p62 protein while preventing the conversion of LC3-I 
to LC3-II (Figure 3C). These results would thus point to a role for the B[a]P-activated NHE1 
pathway in the autophagic dysfunction detected in carcinogen-exposed F258 cells. However, the 
intracellular mechanisms underlying such a role of NHE1 remain to decipher.   
Lysosomes are key organelles in the process of autophagy-driven degradation [110]. A 
first hypothesis considering autophagic dysfunction might therefore be a role for alteration of 
the lysosomal pH. As a reminder, lysosomal pH increased in B[a]P-treated F258 cells [40]. In 
addition, in our cell model, lysosomal dysfunction was related to oxidative stress [40], and this 
latter parameter was notably dependent on NHE1 activation [17]. In this context, it would be 
interesting to more thoroughly test the role of carcinogen-induced NHE1 activation in alterations 
of lysosomal pH. 
We previously identified that B[a]P could potentiate the expression of IF1, the 
physiological inhibitor of the F0F1ATPase [82]. As shown by Campanella and coworkers [111], an 
increase in IF1 in HeLa cells was responsible for an inhibition of autophagy. So a similar 
mechanism might also occur upon B[a]P, especially as IF1 activation was induced, likely resulting 
from the decrease in pHm [26]. Therefore, a role for mNHE1 in the control of autophagy, via IF1 
activation, would also be worth considering. 
B[a]P effects on autophagy might also have their origin in the previously identified 
effects of this carcinogen on HKII [17]. Indeed, beyond its role in the regulation of glycolysis, HKII 
is also able to regulate autophagy via a direct interaction with mTORC1 [112]. This molecular 
interaction would allow adjusting the intensity of autophagic flux on the cell metabolic status, 
with HK2 acting as a switch to integrate both glycolysis and autophagy, thereby increasing cell 
survival during stressful conditions [112]. As HKII translocation has been found to depend on 
NHE1 [17], it would be interesting to carry out immunoprecipitation experiments to check if 
B[a]P is able to slow down autophagic flux by limiting interaction between HKII and mTOR. 
Apart from pH, Nitric Oxide (NO) has recently been shown to inhibit autophagy and to 
promote apoptosis in hepatocellular carcinoma [113]. Thus, NO generation upon B[a]P exposure 
might be another autophagy-regulating pathway to explore. Indeed, we previously found that 
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B[a]P exposure resulted in NO production, that was dependent upon the activation of the 
inducible NO synthase [114].  
As recently reviewed, autophagy dysfunction is associated with many of the chemical-
induced cytotoxic mechanisms, including mitochondrial dysfunction, DNA damage, oxidative 
stress, stress of the endoplasmic reticulum, impairment of lysosomal functions, and 
inflammation [96]. Focusing on B[a]P, our results would thus tend to suggest that activation of 
NHE1 might play a role in the control of autophagy. Accordingly, one might propose that 
alterations of H+ dynamics might be involved in environmental carcinogenesis, notably by 
limiting the cytoprotective capacity afforded by autophagy, especially in non-neoplastic cells. 
 
3-4-Acidic microenvironment and environmental carcinogenesis: an overlooked link 
Even though overlooked regarding B[a]P, the acidification of cell microenvironment, as 
detected using the Seahorse technology in exposed F258 cells [26], might be involved in 
different steps of environmental carcinogenesis, such as impairment of DNA repair and of 
xenobiotic metabolism, inflammation, extracellular matrix degradation and invasion, as well as 
intercellular communication via extracellular membrane nanovesicles. We have previously 
reviewed several aspects of the role of acidic pHe in tumorigenesis and cancer therapy [115]; so 
we will try here to complete the picture, more specifically in link with environmental 
carcinogens. The readers will also find some more information, notably with respect to the 
impact of acidic microenvironment on energy metabolism or dormant tumor cells, in more 
recent reviews [116,117]. 
 
3-4-1-Extracellular acidosis and DNA repair 
It has previously been shown that a low pHe can facilitate the acquisition of chromosomal 
aberrations, i.e. clastogenicity [118]. The maintenance of such aberrations would be facilitated 
by the fact that a low pHe could also alter the DNA repair process [119,120]. Interestingly, data 
obtained by Massonneau and coworkers [121] have recently indicated that even rather small 
variations of pHe (from 7.2 to 6.9) could lead to impairment of the DNA repair; as a result, the 
genotoxicity of double-stranded breaks would be enhanced, leading to genetic instability. In this 
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context, in cells exposed to an environmental carcinogen like B[a]P, one might expect an 
increased probability of mutations under acidic conditions, thus favoring the initiation step. 
Actually, it has been demonstrated by Shi and co-workers [122] that incubating human 
pulmonary epithelial cells (A549 and BEAS-2B) with nontoxic concentrations of B[a]P at acidic 
pHe, resulted in a higher level of B[a]P-DNA adducts and double-stranded breaks. They also 
reported a negative impact on xenobiotic metabolism, especially on the CYP1 expression and 
activity. Indeed, they showed that acidic conditions increased the concentration of un-
metabolized extracellular B[a]P, and that the level of B[a]P-7,8-diol (i.e. a precursor of reactive 
metabolites) was significantly higher under acidic versus normal physiological conditions [122]. 
In addition to an effect on the enzymes of xenobiotic metabolism, a low pHe might also change 
the capacity of cancer cells to cope with oxidative stress. Indeed, a study by Zhao and coworkers 
[123] has shown that a long-term exposure (3 months) of colon cancer cells to acidic 
microenvironment (pHe 6.5), led to a reduction of ROS level associated with a higher level of 
reduced glutathione; such an effect was notably related to an up-regulation of glutathione 
peroxidase.  
 
3-4-2-Extracellular acidosis and vesicle trafficking 
Extracellular acidosis might also favor the release of membrane nanovesicles, similarly to 
what was observed in diverse human cancer cells [124]. These nanovesicles (also referred to as 
exosomes) are membrane vesicles that are produced by all cells, and whose amount and 
composition can vary depending on the physiopathological state of cells or the stress conditions 
[125,126]. These entities play an important role in intercellular communication (notably by 
carrying lipids, proteins, mRNAs, non-coding RNAs like miRNAs), and are now well recognized as 
playing a key role in tumorigenesis [127]. Interestingly, recent data show that the low pHe, a 
known hallmark of tumor neoplasia, could influence exosome release, thereby allowing the 
diffusion of malignancy [124]. Moreover, such an increase in exosome release could serve as a 
means of resistance towards anticancer drugs, as shown for cisplatin; indeed, treated cells would 
use nanovesicles to extrude this molecule in its native form, thereby limiting its efficacy [128]. 
Another study also outlined a role for microenvironmental pH in the internalization of exosomes 
[129]. More specifically, the authors showed that an acidic microenvironment increases the 
entry of nanovesicles into human melanoma cells. They also demonstrated that the increased 
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fusion capacity of exosomes released upon extracellular acidification was associated to an 
increase in membrane rigidity resulting from a change in lipid composition. Under these 
conditions, it could be useful to target extracellular acidification in order to hamper 
tumorigenesis as well as tumor resistance carried by exosomes. Interestingly, even though still in 
its infancy, the study of nanovesicles in the field of environmental carcinogenesis is attracting 
more and more attention [130,131]. 
With respect to trafficking of intracellular vesicles, a drop in pHe has also been described 
to induce profound changes in lysosome characteristics, with notably a significant shift of 
lysosomes from the perinuclear region to the cell periphery in various cancer cells [132]. As 
lysosomes participate in the regulation and function of matrix metalloproteinases (MMPs), 
serine proteases and cathepsins, which are sequestered in these organelles, such a shift to the 
cell periphery may facilitate increased secretion of degradative enzymes [132]. Also note that 
acidic pH is well recognized to participate in the activation of proteases like MMPs and 
cathepsins, thus favoring the degradation of extracellular matrix [133]. However, the 
mechanisms linking acidic extracellular pH and lysosome trafficking remain to be determined 
although a possible role for actin has been put forward. Regarding that point, it is worth noting 
that certain steps in the actin polymerization process and the actin binding to membrane-
anchoring proteins were shown to be associated with changes in pH [134]. With respect to B[a]P, 
it has been shown that exposure of vascular smooth muscle cells to this carcinogen not only 
favors the expression of various MMPs, but also migration and invasion [135]. These two latter 
processes have also been observed with respect to exposure of human hepatocarcinoma cells to 
B[a]P [136]. Therefore, one might suppose that the B[a]P-induced decrease in pHe might be 
involved in the related migration and invasion. In line with this, we previously observed that 
inhibition of NHE1 prevented the B[a]P-induced migration detected in F258 cells [26]. In this 
context, it would be worth analyzing the impact of B[a]P on extracellular vesicle production and 
composition. 
 
3-4-3-Regulation of gene expression 
As stated above, it is now well-recognized that an extracellular acidic pH helps the 
activation of MMPs or other proteases by acting directly on the protein conformation. However, 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21 
 
it has further been shown that pHe may also control the mRNA expression of several MMP 
isoforms as well as of cathepsins. Thus, the mRNA expression of MMP-2, -9, -11 and cathepsins B 
and L, is upregulated under acidic conditions [133,137]. This therefore emphasizes the important 
role of low pHe in the digestion and remodeling of extracellular matrix, both being primordial 
events of the invasive process [138].  
 Cell exposure to a low pHe has also been shown to induce the expression of 
proangiogenic factors such as vascular endothelial growth factor-A (VEGF-A) and interleukin-8 
(IL-8) [133,139], thus indicating that the acidic tumor microenvironment also contributes to 
tumor angiogenesis and progression.  Another function sensitive to extracellular pH, with 
potential important consequences on tumor progression, is the inflammatory response; indeed, 
an extracellular acidification can modulate both pro- and anti-inflammatory responses, notably 
by acting on the expression of diverse cytokines [140-142]. In addition, the low 
microenvironmental pHe inside tumors represents a key mechanism in immune escape and in 
the obstruction of immune mechanisms to attack the tumor [143]. However, regarding 
inflammation, gene transcription would not be the only target for acidic pHe [144]. In line with 
this, more recent studies have found that acidic extracellular environment could also affect the 
miRNA expression, both in vitro and in vivo [145,146]. Circulating miRNAs, like Let-7a that 
regulates several genes linked to inflammation [147], might also be affected by extracellular 
acidosis [148]. Therefore, it seems that an acidic pHe can impact the expression of miRNAs not 
only within cancer cells but also outside (i.e. in biological fluids), with possible consequences at a 
distant site of the initial tumor.  
 The next question that arises is how an extracellular acidification can impact gene and 
miRNA expressions. Despite the evidence for the involvement of different transcription factors 
[115], only a few studies have considered how extracellular H+ can activate them, and more 
precisely how cells can sense the acidic pH to trigger a signaling cascade. Besides a possible role 
for H+-sensitive ion channels, notably resulting in calcium signaling [149], it has been shown that 
several G protein-coupled receptors (GPCR) could also be involved as pHe sensors. This is the 
case for example of the ovarian cancer G-protein-coupled receptor 1 [OGR1] and the G2A that 
respond to extracellular acidification [150,151]. The activation of such GPCRs by acidic pHe might 
involve a change of their trafficking within cells, with more receptors present in the plasma 
membrane, as reported for OGR1 in leukocytes [152].  The result of such an activation might 
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then be an accumulation of cyclic AMP to control proinflammatory cytokine production 
[140,153] or the triggering of calcium signals [140,154]. Other H+-sensitive GPCRs like GPR4 have 
also been shown to be implicated in intestinal inflammation in a mouse model of acute 
experimental colitis [155]. With respect to cancers, it is worth stressing that not only tumor cells 
exhibit a high expression of such receptors, as for example in human medulloblastoma tissues 
[154], but also potent carcinogenic molecules may affect their expression. This is the case for 
example of B[a]P that has been found to increase the expression of GPR68 in exposed 
macrophages [156]. In this context, one might suppose that the B[a]P-exposed cells would then 
be more sensitive to an acidic microenvironment than normal counterparts, due to the increase 
in H+-sensing GPCR expression. This point would be worth exploring in the future. Of note, 
GRP68 has been recently proposed as an emerging drug target in cancer [157]. 
 
4-CONCLUSION 
Our works on B[a]P have clearly evidenced changes in H+ dynamics upon exposure to low doses 
of this carcinogen (i.e. doses more relevant to human exposure), likely relying, for most of them, 
on activation of NHE1. This activation that occurs in parallel to the canonical genotoxic pathway, 
has been found to have important consequences in terms of regulation of the balance between 
cell death and survival, notably by acting on mitochondria and energetic metabolism. Thus, the 
impact of B[a]P on H+ dynamics is in line with the proton gradient reversal (high pHi/low pHe) 
known to be a selective and new hallmark of malignant tumors. Apart from B[a]P and arsenic 
salts, it can then be suggested that the carcinogenic activity of many other carcinogens of 
different origins and natures could share the same and/or similar pathways and effects on 
cellular H+ dynamics, thus leading to the possibility for NHE1 and/or other proton extruders’ 
upregulation and overexpression to be universal mechanisms in environmental carcinogenesis.  
Based upon the fact that alterations in H+ dynamics are related to several, if not all, cancer 
hallmarks, these studies therefore emphasize the need to further consider this important 
parameter when analyzing the carcinogenesis process induced by environmental pollutants. 
Indeed, such investigations could lead to the identification of new targets in order to prevent, or 
at least limit, deleterious impacts of these xenobiotics.  
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FIGURE LEGENDS 
 
Figure 1. The different phases of xenobiotic metabolism. Following cell exposure, a xenobiotic 
(X) will be transformed into a molecule that will be easily eliminated. This transformation occurs 
through several phases that notably involved different enzymatic activities such as cytochrome 
P450s (CYPs) and glutathione-S-transferases regarding phases 1 and 2, respectively. However 
such a multi-enzymatic process can also lead to the production of reactive metabolites (X*) and 
reactive oxygen species (ROS), which then can lead to deleterious effects towards several cell 
constituents. 
Figure 2. Impact of benzo[a]pyrene (B[a]P) on H+ dynamics. Upon B[a]P exposure, the H+ 
dynamics have been shown to be altered, thus resulting in variations in intracellular (pHi) and 
extracellular pH (pHe) as well as in the pH of both mitochondrial matrix (pHm) and lysosomes 
(pHL). All these changes lead to either disappearance or reversal of pH gradient across 
membranes (as illustrated by dotted arrows), when compared to physiological conditions. 
Figure 3. Impact of B[a]P exposure on the autophagy process in rat hepatic epithelial F258 
cells. Cells were treated or not with 50 nM or 1 µM B[a]P for 36-72h (A), 24h (B) or 48h (C).  
Western-blots show the expression of p62 and LC3-II, two autophagic markers, in presence (C) or 
not (A) of cariporide, the specific inhibitor of NHE1. Autophagic vacuoles and aggresomes were 
visualized by fluorescence imaging in cells treated either with B[a]P (50 nM, 24h) (B). 
Chloroquine (CHL, 10 µM) was used as positive control of autophagy. 
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Table 1: Possible targets for alterations in H
+
 dynamics due to environmental carcinogens. 
This table shows the different possible targets for changes in intracellular pH (pHi) or extracellular 
pH (pHe), as well as for changes in the pH of both mitochondrial matrix (pHm) and lysosomes (pHL) 
that would occur upon exposure to environmental carcinogens. 
HKII: hexokinase II; ETC: mitochondrial electron transport chain ; IF1 : inhibitory factor 1 ; ECM : 
extracellular matrix; GPCR: G protein coupled receptor. 
 
 
Alkaline pHi 
-membrane characteristics (fluidity) 
-activity of metabolic enzymes  
-protein interactions (HKII) 
-activity of F0F1-ATPase 
-gene expression 
… 
 
Acid pHm 
-activity of ETC complexes (eg. complex II) 
-activation of IF1 
… 
 
Alkaline pHL 
-pHi homeostasis 
-autophagy process 
-iron homeostasis 
-caspase activation through protease release 
… 
 
Acid pHe 
-DNA repair 
-vesicle trafficking and release 
-activity of ECM enzymes 
-gene expression 
-miRNA expression 
-pH-sensitive GPCR activation 
…. 
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HIGHLIGHTS 
Benzo[a]pyrene, a well-known environmental carcinogen, alters H
+
 dynamics.  
NHE1 activation by B[a]P plays a key role in H
+
 dynamics alterations. 
B[a]P-altered pH controls cell death/survival balance via mitochondria and lysosome. 
B[a]P impact on H
+
 dynamics fits with the malignant tumor-related H
+ 
gradient reversal. 
Altered H
+
 dynamics might be universal mechanisms in environmental carcinogenesis. 
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